Literature DB >> 31079269

Changes in the metabolic composition of storage solution with prolonged cold ischemia of the uterus.

Antoine Tardieu1,2, P Chazelas3,4, P-A Faye3,4, F Favreau3,4, L Nadal-Desbarats5, C Sallée6, F Margueritte6, C-Y Couquet7, P Marquet8, C Barin-Le Guellec8,5, T Gauthier8,6.   

Abstract

INTRODUCTION: The development of uterine transplantation (UTx) from deceased donors requires knowledge of the tolerance of the uterus to prolonged cold ischemia (CI). This can be evaluated through the use of biological parameters to assess degradation of the organ between its procurement and transplantation. The objective of this study was to analyze changes in the metabolic composition of the storage solution in cases of prolonged CI in uteri from ewes.
METHODS: Eighteen uterine auto-transplantations were performed in ewes. CI time was 1 h (T1) or 24 h (T24). Samples of Celsior® were taken when the explanted uterus was flushed (T0) and at the end of CI. A dual approach to metabolic analyses was followed: targeted biochemical analyses targeting several predefined metabolites and non-targeted metabolomics analyses based on nuclear magnetic resonance (NMR).
RESULTS: Metabolic analyses were performed on 16 explanted uteri. Metabolomic profiles differed significantly between T1 and T24 (p = 0.003). Hypoxia-associated degradation of the organ was demonstrated by the significantly higher lactate levels at T24 than at T1 (p < 0.05), accompanied by cell lysis, and significantly higher levels of creatine kinase activity in T24 than in T1 uteri (p < 0.05). Oxidative stress increased over time, with a significantly higher oxidized glutathione/glutathione ratio for T24 than for T1 uteri (p < 0.05).
CONCLUSION: The metabolic results indicate a significant degradation of the uterus during 24 h of CI. Metabolic analysis of the storage solution could be used as a non-invasive tool for evaluating uterine degradation during CI before transplantation.

Entities:  

Keywords:  Cold ischemia; Metabolic changes; Uterine transplantation; Uterus transplantation

Mesh:

Year:  2019        PMID: 31079269      PMCID: PMC6603114          DOI: 10.1007/s10815-019-01477-y

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  3 in total

Review 1.  The Fetal-Maternal Immune Interface in Uterus Transplantation.

Authors:  Jasper Iske; Abdallah Elkhal; Stefan G Tullius
Journal:  Trends Immunol       Date:  2020-03       Impact factor: 16.687

Review 2.  Uterus transplantation: state of the art in 2021.

Authors:  Elliott G Richards; Ruth M Farrell; Stephanie Ricci; Uma Perni; Cristiano Quintini; Andreas Tzakis; Tommaso Falcone
Journal:  J Assist Reprod Genet       Date:  2021-05-31       Impact factor: 3.357

Review 3.  Involving Animal Models in Uterine Transplantation.

Authors:  Angeline Favre-Inhofer; Marie Carbonnel; Johanna Domert; Nathalie Cornet; Sylvie Chastant; Raphaël Coscas; François Vialard; Valérie Gelin; Laurent Galio; Christophe Richard; Héla Trabelsi; Olivier Sandra; Dominique de Ziegler; Pascale Chavatte-Palmer; Jean-Marc Ayoubi
Journal:  Front Surg       Date:  2022-02-23
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.